Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Non-Small-Cell Lung × Metformin × Clear all

Phase

Phase 2 11 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 19 Insulin Resistance 5 Obesity 3 Neoplasms 3 Prostatic Neoplasms 2 Menstruation Disturbances 2 Medulloblastoma 2 Diabetes Mellitus 2 Breast Neoplasms 2 Weight Loss 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Premature Birth 1 Prediabetic State 1 Pre-Eclampsia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Non-DM Stage II High-risk Colorectal Cancer 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Motor Activity 1 Metabolic Syndrome 1 Infertility, Female 1 Infertility 1 Hyperandrogenism 1 Female 1 Endometrial Neoplasms 1 Diabetes Mellitus, Type 2 1 Colorectal Neoplasms 1

Interventions

Carboplatin 162 Cisplatin 133 Pemetrexed 125 Paclitaxel 108 Docetaxel 92 pembrolizumab 75 Gemcitabine 57 Erlotinib Hydrochloride 42 Radiotherapy 35 durvalumab 29 Gefitinib 29 Vinorelbine 26 Bevacizumab 24 Nivolumab 22 Drug Therapy 21 atezolizumab 18 130-nm albumin-bound paclitaxel 16 osimertinib 15 tislelizumab 14 Radiosurgery 13 Crizotinib 13 Etoposide 12 Afatinib 10 aumolertinib 9 Surgical Procedures, Operative 9 Albumin-Bound Paclitaxel 9 icotinib 8 Specimen Handling 8 Observation 8 Ipilimumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05445791 2023-06-27

METLUNG

Instituto Nacional de Cancerologia de Mexico

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡